Align Technology, Inc. vs Roundhill Russell 2000 0DTE Covered Call Strat ETF — how do they compare? Align Technology, Inc. trades at $179.9 (market cap $12.86B), while Roundhill Russell 2000 0DTE Covered Call Strat ETF trades at $28.81. The key difference: Align Technology, Inc. is trading nearer its 52-week high, Roundhill Russell 2000 0DTE Covered Call Strat ETF nearer its low. Which is the better fit depends on your goals.
| ALGN | RDTE | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $207.19 | $34.72 |
52-Week Low | $124.88 | $26.40 |
Enterprise Value | $11.92B | — |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
RDTE trades at $28.9, down 0.34% today, with technical indicators signaling a bearish trend. The stock exhibits frequent dividend distributions, but key valuation and profitability ratios are unavailable. Recent news highlights structural risks to capital preservation.
Outlook remains cautious due to technical weakness and media concerns over capital erosion. Investment opportunity is limited without fundamental data; risks include downside exposure and capped upside potential from the ETF's strategy.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →RDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the Russell 2000 Index. The fund primarily holds a portfolio of short-term U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the Russell 2000. This highly tactical strategy aims to maximize premium capture by exploiting the high time decay of options that are expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.
Read more on RDTE →